India Approves Takeda's Qdenga: First Dengue Vaccine for Ages 4-60

India's first dengue vaccine, Takeda's Qdenga, has been approved for individuals aged 4 to 60. This significant health advancement aims to combat dengue fever, a major public health concern in tropical regions. With this approval, India joins the global fight against dengue, offering hope to millions at risk. The vaccine's introduction is expected to enhance preventive measures and reduce the burden of this mosquito-borne disease.